BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gil-García AI, Madejón A, Francisco-Recuero I, López-López A, Villafranca E, Romero M, García A, Olveira A, Mena R, Larrubia JR, García-Samaniego J. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment. World J Gastroenterol 2019; 25(38): 5883-5896 [PMID: 31636479 DOI: 10.3748/wjg.v25.i38.5883]
URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5883.htm
Number Citing Articles
1
Wei Zhang, Hui-Fang Kong, Xu-Dong Gao, Zheng Dong, Ying Lu, Jia-Gan Huang, Hong Li, Yong-Ping Yang. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(35): 5287-5301 doi: 10.3748/wjg.v26.i35.5287
2
William S. Mason, Allison R. Jilbert, Samuel Litwin. Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected LiverViruses 2021; 13(2): 210 doi: 10.3390/v13020210
3
Wenbin Liu, Shiliang Cai, Rui Pu, Zixiong Li, Donghong Liu, Xinyu Zhou, Jianhua Yin, Xi Chen, Liping Chen, Jianfeng Wu, Xiaojie Tan, Xin Wang, Guangwen Cao. HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory SignalingCancers 2022; 14(13): 3274 doi: 10.3390/cancers14133274
4
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resectionLiver International 2022; 42(2): 288 doi: 10.1111/liv.15124